TY - JOUR
T1 - Cyclic nucleotide compartmentalization
T2 - Contributions of phosphodiesterases and ATP-binding cassette transporters
AU - Cheepala, Satish
AU - Hulot, Jean Sebastien
AU - Morgan, Jessica A.
AU - Sassi, Yassine
AU - Zhang, Weiqiang
AU - Naren, Anjaparavanda P.
AU - Schuetz, John D.
PY - 2013/1
Y1 - 2013/1
N2 - Cyclic nucleotides e.g., cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) are ubiquitous second messengers that affect multiple cell functions from maturation of the egg to cell division, growth, differentiation, and death. The concentration of cAMP can be regulated by processes within membrane domains (local regulation) as well as throughout a cell (global regulation). The phosphodiesterases (PDEs) that degrade cAMP have well-known roles in both these processes. It has recently been discovered that ATP-binding cassette (ABC) transporters contribute to both local and global regulation of cAMP. This regulation may require the formation of macromolecular complexes. Some of these transporters are ubiquitously expressed, whereas others are more tissue restricted. Because some PDE inhibitors are also ABC transporter inhibitors, it is conceivable that the therapeutic benefits of their use result from the combined inhibition of both PDEs and ABC transporters. Deciphering the individual contributions of PDEs and ABC transporters to such drug effects may lead to improved therapeutic benefits.
AB - Cyclic nucleotides e.g., cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) are ubiquitous second messengers that affect multiple cell functions from maturation of the egg to cell division, growth, differentiation, and death. The concentration of cAMP can be regulated by processes within membrane domains (local regulation) as well as throughout a cell (global regulation). The phosphodiesterases (PDEs) that degrade cAMP have well-known roles in both these processes. It has recently been discovered that ATP-binding cassette (ABC) transporters contribute to both local and global regulation of cAMP. This regulation may require the formation of macromolecular complexes. Some of these transporters are ubiquitously expressed, whereas others are more tissue restricted. Because some PDE inhibitors are also ABC transporter inhibitors, it is conceivable that the therapeutic benefits of their use result from the combined inhibition of both PDEs and ABC transporters. Deciphering the individual contributions of PDEs and ABC transporters to such drug effects may lead to improved therapeutic benefits.
KW - CFTR
KW - MRP4
KW - cAMP
KW - efflux
KW - export
UR - http://www.scopus.com/inward/record.url?scp=84872226985&partnerID=8YFLogxK
U2 - 10.1146/annurev-pharmtox-010611-134609
DO - 10.1146/annurev-pharmtox-010611-134609
M3 - Review article
C2 - 23072381
AN - SCOPUS:84872226985
SN - 0362-1642
VL - 53
SP - 231
EP - 253
JO - Annual Review of Pharmacology and Toxicology
JF - Annual Review of Pharmacology and Toxicology
ER -